Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer.

MLA

Wang, Hui-Ching, et al. “Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer.” International Journal of Medical Sciences, vol. 19, no. 10, Sept. 2022, pp. 1615–27. EBSCOhost, https://doi.org/10.7150/ijms.73800.

APA

Wang, H.-C., Shih, H.-Y., Wu, C.-C., Chen, L.-T., Luo, C.-W., Liu, Y.-C., Du, J.-S., Huang, M.-C., Su, Y.-Y., Chen, H.-D., Hsiao, H.-H., Moi, S.-H., & Pan, M.-R. (2022). Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer. International Journal of Medical Sciences, 19(10), 1615–1627. https://doi.org/10.7150/ijms.73800

Chicago

Wang, Hui-Ching, Hsiang-Yao Shih, Chun-Chieh Wu, Li-Tzong Chen, Chi-Wen Luo, Yi-Chang Liu, Jeng-Shiun Du, et al. 2022. “Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer.” International Journal of Medical Sciences 19 (10): 1615–27. doi:10.7150/ijms.73800.